We di dɔktɔ tɛl yu se yu gɛt dayabitis, di fɔs tin we kin kam na yu maynd na fɔ kɔntrol yu blɔd shuga. Bɔt yu no se dayabitis we yu nɔ kɔntrol kin pwɛl ɔda impɔtant pat na yu bɔdi sikrit wan, we na di kidni? Dis nɔto tin we kin apin to bɔku pipul dɛn, bɔt na kɔmɔn prɔblɛm we kin kam wit dayabitis. Dɛn kin kɔl dis sik bak Dayabitik Kidni Disiz (DKD), Kronik Kidni Disizin (CKD) ɔ Dayabitik Nɛfrɔpati. So tide, lɛ wi tɔk bɔt di kɔnekshɔn bitwin dayabitis ɛn kidni sik.
Aw dis kin apin?
Fɔ tɔk am simpul wan, yu kidni dɛn tan lɛk filta na yu bɔdi. di men wok we di kidni dεm de du na fכ filta di dɔti tin dεm we de kכmכt na di bכdi εn pas dεm kכmכt na di bכdi as urine.
We yu gɛt Tayp 2 Dayabitis, yu blɔd shuga kin de ɔp ɔltɛm. Tink bɔt am, insay dɛn kidni ya, bɔku bɔku rili fayn, smɔl smɔl filta dɛn de, we wi kin kɔl glomeruli. We yu blɔd shuga de bɔku ɔltɛm, dɛn kin put dɛn smɔl smɔl filta dɛn ya ɔnda bɔku strɛs. I tan lɛk se ti filta de klos we yu de filta dɔti wata ɔltɛm.
We dɛn put dis prɛshɔn as tɛm de go, dɛn fayn fayn filta dɛn ya kin bigin fɔ pwɛl. afta dat, ivin tin dεm lεk albumin, we na imכtant protin we di bכdi nid fכ kip, kin bigin fכ lik tru dεn filta dεm ya εn kכmכt wit di urine. in כda wod dεm, di protin de bigin fכ "lik" frכm di kidni dεm.
Di simptom dɛm ɛn di ditekshɔn
De tin wae de frayd pasmak pan dis na dat , wae yu de bigin, yu nɔr kin gɛt ɛni sayn. Pan ɔl we yu kidni dɛn dɔn ɔlrɛdi pwɛl, yu nɔ go fil natin bɔt dat.
Na dat mek i rili impɔtant fɔ mek dɛn du yu dɔktɔ in kidni tɛst di rayt tɛm.
Fɔ dis, dɛn kin mɔs tɛst wan urine sɛmpul ɛn blɔd sɛmpul.
- Yurin tɛst: If di kidni dɛn nɔ de wok fayn, wan prɔtin we dɛn kɔl albumin go de insay di urine tumɔs.
- Blɔd tɛst: Dis kin chɛk if yu kidni dɛn de filta blɔd fayn fayn wan.
Di tebul we de dɔŋ ya de sho di difrɛns bitwin dɛn tu stej ya.
| Stej we di sik de | Tin dɛn fɔ si |
|---|---|
| Di Fɔs Stej | No sayn nɔ de fɔ sho se i gɛt dis sik. So, di wangren we fɔ no if yu gɛt dis sik na fɔ du di tɛst we yu dɔktɔ tɛl yu fɔ du. |
| We di sik de go bifo (Leta Stej) . |
|
Us tin dɛn kin mek di prɔblɛm bɔku?
Di mɔ we yu nɔ ebul fɔ kɔntrol yu dayabitis, na di mɔ yu go gɛt sik na yu kidni. If yu blɔd shuga de bɔku ɔltɛm, yu kin gɛt prɔblɛm wit yu kidni.
Apat frɔm dat, dɛn tin ya kin mek di prɔblɛm kin bɔku bak:
- Fɔ gɛt ay blɔd prɛshɔn
- Fɔ smok
- Fɔ gɛt kidni sik pan pɔsin na di famili (mama, papa, brɔda ɛn sista dɛn) .
- Fɔ gɛt at sik
- We yu de gɛt bɔku bɔku wet (we yu fat pasmak) .
- Nɔ de du ɛksɛsayz fɔ yu bɔdi
- Nɔ fala di rayt it fɔ kɔntrol dayabitis
- Ad tumɔs sɔl (sɔdiɔm) to it
Aw fɔ protɛkt di kidni dɛn? (Prɛvenshɔn) .
Di impɔtant tin we yu kin du fɔ protɛkt yu kidni na fɔ kɔntrol yu dayabitis. Dat nɔmɔ kin mek yu nɔ gɛt sik na yu kidni bay lɛk wan pat pan tri pat. Dat min se, .
- Fɔ chɛk di blɔd shuga lɛvɛl ɔltɛm
- Fɔ tek di mɛrɛsin jɔs lɛk aw di dɔktɔ tɛl yu fɔ tek am
- Fɔ fala di rayt it
- Fɔ atɛnd klinik dɛn di de dɛn we dɛn dɔn sɛtul
Dɔn bak, if yu gɛt ɔda sik dɛn lɛk ay blɔd prɛshɔn, i impɔtant fɔ kɔntrol dɛn fayn fayn wan.
I rili impɔtant fɔ mek yu nɔ tek mɛrɛsin fɔ mek yu nɔ gɛt pen we yu nɔ go to yu dɔktɔ. Sɔm tin dɛn we de mek yu nɔ fil pen kin pwɛl yu kidni if yu yuz am fɔ lɔng tɛm. So, if yu de fil pen, aks yu dɔktɔ wetin na di mɛrɛsin we sef fɔ tek.
If yu de smok, lɛf fɔ smok tide. If yu fat pasmak, lɛf fɔ it bɔku bɔku it dɛn. Yu dɔktɔ kin ɛp yu wit ɔl dɛn tin ya.
Wetin na di tritmɛnt dɛn?
If tɛst sho se yu kidni dɔn pwɛl, di fɔs tin we yu dɔktɔ go want fɔ du na fɔ stɔp di sik fɔ mek i nɔ wɔs. Fɔ du dis, dɛn go mek wan plan fɔ ɛp yu fɔ kɔntrol yu blɔd shuga ɛn blɔd prɛshɔn.
Sɔm tin dɛn de we yu kin du fɔ dis bak:
- If yu bɔdi bɔku pasmak, lɛf fɔ it bɔku bɔku it dɛn.
- Fɔ du ɛksasaiz ɔltɛm
- Nɔ drink rɔm ɛn sigrɛt kpatakpata
- Fɔ ridyus di sɔl we yu de it
Mɛrɛsin dɛn kin ɛp bak. Dɛn dɔn sho se sɔm mɛrɛsin dɛn fɔ ay blɔd prɛshɔn, lɛk ACE inhibitors ɛn ARB, kin mek di sik we de na di kidni nɔ go bifo kwik kwik wan. Ivin if yu nɔ gɛt ay blɔd prɛshɔn, yu dɔktɔ kin gi yu dɛn mɛrɛsin ya fɔ protɛkt yu kidni. Apat frɔm dat, nyu klas dɛm fɔ dayabitis mɛrɛsin, lɛk SGLT2 inhibitors , GLP-1 agonists, ɛn nonsteroidal mineralocorticoid receptor antagonists (MRAs), kin ɛp bak fɔ kɔntrol kidni sik we dayabitis kin kam wit.
Dɔn bak, yu dɔktɔ go advays yu fɔ ridyus di prɔtin we yu de it fɔ ridyus di strɛs we de pan yu kidni.
Wetin na Kidni Failure?
If di sik na di kidni go go bifo to wan stej we dεn kכl kidni fεil, i min se yu kidni dεm de wok pan 10% to 15% pan dεn nכmal kapasiti. Dis min se di kidni dɛn nɔ ebul fɔ du di wok fɔ klin ɛn pul wata we dɛn nid fɔ mek di bɔdi kɔntinyu fɔ wok.
Wi kin kɔl dis kɔndishɔn Ɛnd-Stej Rɛnal Disiz (ESRD). Dɛn sik pipul ya nid fɔ gɛt dayalaysis ɔ fɔ transplant dɛn kidni fɔ mek dɛn kɔntinyu fɔ liv.
Bɔt nɔ mek yu fred. Nɔto ɔlman wae gɛt kidni sik bikɔs ɔf dayabitis go gɛt dis siriɔs sik. Bɔrku pipul dɛn kin ebul fɔ kɔntrol di sik wit di rayt tritmɛnt ɛn chenj dɛn layf.
Di tin we impɔtant pas ɔl na fɔ kɔntrol yu dayabitis fayn fayn wan, tek kia ɔf yu wɛlbɔdi biznɛs, ɛn fala di tɛst ɛn tritmɛnt dɛn we yu dɔktɔ tɛl yu fɔ du.
Mɛsej we dɛn kin kɛr go na os
- Dayabitis we yu nɔ kɔntrol kin pwɛl yu kidni sikrit wan.
- Bikɔs no sayn nɔ de fɔ di fɔs tɛm, i impɔtant fɔ mek yu nɔ skip di urine ɛn blɔd tɛst we yu dɔktɔ tɛl yu fɔ du.
- Di bɛst we fɔ protɛkt yu kidni na fɔ kɔntrol yu blɔd shuga ɛn blɔd prɛshɔn.
- Mek shɔ se yu tɔk to yu dɔktɔ bifo yu yuz ɛni nyu mɛrɛsin, mɔ di mɛrɛsin dɛn we de mek yu nɔ fil pen.
- Fɔ liv fayn layf (gud it, ɛksesaiz, ɛn fɔ lɛf fɔ smok) kin rili kɔntrol aw di sik kin go bifo pan di kidni.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt